On Topic Virtual Roundtable: EGFR Mutant Metastatic NSCLC - Updates on Testing, Treatment, Adverse Event Management, and Patient Education
On Topic Virtual Roundtable: EGFR Mutant Metastatic NSCLC - Updates on Testing, Treatment, Adverse Event Management, and Patient Education is organized by Bio Ascend LLC.
Release Date: March 28, 2023
Expiration Date: March 28, 2024
Learning Objectives:
After participating in this activity, participants should be better able to:
• Assess current testing guidelines for patients diagnosed with metastatic NSCLC, including recommendations for EGFR and MET testing
• Evaluate current therapies available for patients with NSCLC that harbor EGFR mutations and alterations, including safety and efficacy results from pivotal clinical trials
• Identify mitigation strategies to combat treatment-related adverse events that may occur with the use of EGFR-directed therapies, and educate patients and caregivers regarding these adverse events
Topics of Discussion:
Module 1: Testing Guidelines for Patients With Metastatic NSCLC
Module 2: Treating Patients With EGFR Mutant NSCLC
Module 3: Adverse Event Management Strategies
Module 4: Patient/Caregiver Education.